Company

Nordic Nanovector

As of the edition of 20 October 2026, Nordic Nanovector runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Stopped2
Total2

Where its trials are

  • Blood and lymph: 4 trials led
  • Cancer: 4 trials led
  • Immune system: 4 trials led